Interestingly, T0070907 was also reported to suppress breast cancer cell proliferation and motility in a PPARγ-dependent manner51, meaning that at least some part of the cytotoxic activity of deoxyelephantopin may indeed originate from antagonizing this receptor. The gene discussed is PPARG; the disease is breast carcinoma.